A5051394898- Coronary Interventions and Diagnostics
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Mechanical Circulatory Support Devices
- Peripheral Artery Disease Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Structural Anomalies and Repair
- Vascular Procedures and Complications
- Infective Endocarditis Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Function and Risk Factors
- Fatty Acid Research and Health
- Cardiac Arrest and Resuscitation
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Cardiac and Coronary Surgery Techniques
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Arrhythmias and Treatments
- Hemodynamic Monitoring and Therapy
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Cardiovascular Issues in Pregnancy
MedStar Washington Hospital Center
2019-2025
MedStar Georgetown University Hospital
2022-2025
Georgetown University
2022-2025
Washington Hospital
2022-2023
University of Maryland, Baltimore
2022
[Figure: see text].
Background Fractional flow reserve (FFR) measurement is commonly used in the cardiac catheterization laboratory to assess functional significance of coronary arterial plaques. Robust real-world data on complications and modes failure FFR guidewires are limited. Aim To characterize these outcomes by analyzing post-marketing surveillance from United States Food Drug Administration Manufacturer User Facility Device Experience (MAUDE) database for guidewires. Methods The MAUDE was queried...
Despite advances in transcatheter aortic valve replacement (TAVR) technology, periprocedural stroke remains a complication of TAVR procedures. The TriGUARD 3 device is designed to be positioned the arch deflect debris away from brachiocephalic, left common carotid, and subclavian arteries during TAVR. United States Food Drug Administration (FDA) assembled Circulatory System Devices Panel review safety effectiveness data for device. Because coronavirus disease 2019 pandemic, this meeting was...
Abstract Background With advances in technology and technique, the expectations are that patients undergoing procedures cardiac catheterization laboratory will not need to return for a repeat procedure within same day. Objectives Report why subjects urgently during Methods We retrospectively reviewed who were brought back day procedure. The reasons index identified. Patients transferred from an outside center after initial at other centers excluded. Results Between November 2013 January...